SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

ICE-100E Incubation Chamber

The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.

HCV Rapid Quantitative Test

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

LH Rapid Quantitative Test (Chemiluminescence Immunoassay)

LH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Luteinizing hormone (LH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

RSV Antigen Rapid Test

The RSV antigen rapid test is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute RSV virus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B